| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Mesa Laboratories, Inc.
13G/A
Amendment 2
MLAB · 59064R109
|
8.6% |
7/7/2026
Event 6/30/2026
|
|||
| Long Path Smaller Companies Fund, LP | 8.6% | ||||
| Long Path Fund GP, LLC | 8.6% | ||||
| Long Path Partners, LP | 8.6% | ||||
| Long Path Holdings LLC | 8.6% | ||||
| William Thomas Brennan | 8.6% | ||||
| Brian Paul Nelson | 8.6% | ||||
|
Mesa Laboratories, Inc.
13G/A
Amendment 1
MLAB · 59064R109
|
7.3% |
4/15/2026
Event 3/31/2026
|
|||
| Long Path Smaller Companies Fund, LP | 7.3% | ||||
| Long Path Fund GP, LLC | 7.3% | ||||
| Long Path Partners, LP | 7.3% | ||||
| Long Path Holdings LLC | 7.3% | ||||
| William Thomas Brennan | 7.3% | ||||
| Brian Paul Nelson | 7.3% | ||||
|
Mesa Laboratories, Inc.
13G
MLAB · 59064R109
|
5.6% |
3/13/2026
Event 3/11/2026
|
|||
| Long Path Smaller Companies Fund, LP | 5.6% | ||||
| Long Path Fund GP, LLC | 5.6% | ||||
| Long Path Partners, LP | 5.6% | ||||
| Long Path Holdings LLC | 5.6% | ||||
| William Thomas Brennan | 5.6% | ||||
| Brian Paul Nelson | 5.6% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.